Horizon Discovery to Distribute Haplogen's Haploid Cellular Models | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has inked a worldwide distribution deal covering Haplogen's haploid cellular models.

Under the terms of the deal, effective immediately, customers will be able to purchase directly from Horizon, Haplogen's Haploid Gene Trap Mutant Collection of isogenic human cell lines deficient for the expression of single genes. Horizon said the deal is its first covering the distribution of another company's products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.